BrosMed Announces CE Mark and Launch for Artimes™ Balloon Dilatation Catheter
Release time:
2013-10-21
October 19, 2013– BrosMed announced CE Mark and launch of its Artimes™ Balloon Dilatation Catheter, which is now approved in the EU for the purpose of improving myocardial blood flow in the localized stenotic lesion of the coronary arteries.
October 19, 2013– BrosMed announced CE Mark and launch of its Artimes™ Balloon Dilatation Catheter, which is now approved in the EU for the purpose of improving myocardial blood flow in the localized stenotic lesion of the coronary arteries.
“We are so pleased to receive the CE Mark & launch the product to the EU market and we are expanding ourselves to other territories as well, the Artimes™ balloon catheter is new product which was designed by 10+ year experienced R&D team in the industry and now CE approval. We hope it will help physicians and benefit the patients” said Benny Lee, Chairman of the company.
Join Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announces Canadian Approval of RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical today announced Canadian regulatory approval of the RevoEdge™ High-Pressure Cutting Balloon Dilatation Catheter, expanding the company’s presence in North America and marking another milestone in the global commercialization of its specialty coronary portfolio.
2026-09-14
BrosMed Announced CE MDR Approval of VascuGlide™ Microcatheter System
June 15, 2026-BrosMed is pleased to announce that the VascuGlide™ Microcatheter System has received CE MDR certification, marking another significant milestone in the company's commitment to advancing peripheral intervention solutions.
2026-06-18
